Press release CROSSJECT completes €5 million financing with Vatel Capital DIJON, France - November 14th, 2025 (8.30 PM CET) - CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback